Bloodwork question about pramiracetam. Baseline, a fortnight in, and the numbers moved in a direction I did not expect.
Mechanism is not outcome, and a plausible pathway is the most expensive kind of evidence there is.
Cold storage, light protection, and a date on the vial. Boring, and it removes half the variables.
The effect size I actually noticed is roughly a third of what the write-ups imply, and it took a fortnight to be sure.
The comparison group matters more than the compound when the outcome is something as fuzzy as focus.
Headache is the classic first-week effect and choline usually sorts it.
Where does the human data stop and the extrapolation start?
Same here.
Not on pramiracetam but the pattern is familiar.
Most of the popular protocol is borrowed from a clinical population and applied to healthy people without comment.
Stupid question: how do you know whether what is in the vial matches the label at all?